These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 10474253)
1. Effect of oligomer length and base substitutions on the cytotoxic activity and specific nuclear protein recognition of GTn oligonucleotides in the human leukemic CCRF-CEM cell line. Morassutti C; Dapas B; Scaggiante B; Paroni G; Xodo L; Quadrifoglio F Nucleosides Nucleotides; 1999; 18(6-7):1711-6. PubMed ID: 10474253 [TBL] [Abstract][Full Text] [Related]
2. Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth. Morassutti C; Scaggiante B; Dapas B; Xodo L; Tell G; Quadrifoglio F Biochimie; 1999 Dec; 81(12):1115-22. PubMed ID: 10607406 [TBL] [Abstract][Full Text] [Related]
3. Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding proteins. Scaggiante B; Morassutti C; Dapas B; Tolazzi G; Ustulin F; Quadrifoglio F Eur J Biochem; 1998 Mar; 252(2):207-15. PubMed ID: 9523690 [TBL] [Abstract][Full Text] [Related]
4. Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Dapas B; Tell G; Scaloni A; Pines A; Ferrara L; Quadrifoglio F; Scaggiante B Eur J Biochem; 2003 Aug; 270(15):3251-62. PubMed ID: 12869201 [TBL] [Abstract][Full Text] [Related]
5. Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines. Scaggiante B; Dapas B; Grassi G; Manzini G FEBS J; 2006 Apr; 273(7):1350-61. PubMed ID: 16689924 [TBL] [Abstract][Full Text] [Related]
6. Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cells. Scaggiante B; Dapas B; Perissin L; Manzini G Biochimie; 2005 Aug; 87(8):713-23. PubMed ID: 16054525 [TBL] [Abstract][Full Text] [Related]
7. Alpha-anomeric configuration of GT oligodeoxynucleotide leads to loss of the specific aptameric and cytotoxic properties retained by the beta-anomeric analog. Scaggiante B; Dapas B; Quadrifoglio F Antisense Nucleic Acid Drug Dev; 2001 Dec; 11(6):395-9. PubMed ID: 11838641 [TBL] [Abstract][Full Text] [Related]
8. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate. Romanini A; Chou TC; Bertino JR Adv Enzyme Regul; 1989; 28():323-33. PubMed ID: 2533849 [TBL] [Abstract][Full Text] [Related]
9. Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin. Weidner DA; Valdez BC; Henning D; Greenberg S; Busch H FEBS Lett; 1995 Jun; 366(2-3):146-50. PubMed ID: 7789533 [TBL] [Abstract][Full Text] [Related]
10. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939 [TBL] [Abstract][Full Text] [Related]
12. Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T lymphoblastic drug-sensitive and multidrug-resistant cells. Dapas B; Perissin L; Pucillo C; Quadrifoglio F; Scaggiante B Antisense Nucleic Acid Drug Dev; 2002 Aug; 12(4):247-55. PubMed ID: 12238813 [TBL] [Abstract][Full Text] [Related]
13. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. Bugg BY; Danks MK; Beck WT; Suttle DP Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758 [TBL] [Abstract][Full Text] [Related]
14. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis. Nandy P; Periclou AP; Avramis VI Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064 [TBL] [Abstract][Full Text] [Related]
16. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides. Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides. Mayfield C; Squibb M; Miller D Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2. Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027 [TBL] [Abstract][Full Text] [Related]
20. Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM. Schwarze CP; Neu S; Beck J; Mavridou K; Ranke MB; Binder G Horm Res; 1999; 52(4):192-9. PubMed ID: 10725785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]